Company:  EYENOVIA, INC. (EYEN)
Form Type:  424B5
Filing Date:  7/11/2019 
CIK:  0001682639 
Address:  8748 TECHNOLOGY WAY 
City, State, Zip:  RENO, Nevada 89521 
Telephone:  813-766-9539 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.19  
Change: 
0.01 (0.31%)  
Trade Time: 
Jul 19  
Market Cap: 
$52.45M
Trade EYEN now with 

© 2019  
Description of Business
We were organized as a corporation under the laws of the State of Florida on March 12, 2014 under the name "PGP Holdings V, Inc." On May 5, 2014, we changed our name to Eyenovia, Inc. On October 6, 2014, we reincorporated in the State of Delaware by merging into Eyenovia, Inc., a Delaware corporation. Our principal executive office is located at 295 Madison Avenue, Suite 2400, New York, NY 10017, and our phone number is 917-289-1117. Our website is http://www.eyenoviabio.com. Information contained on, or that can be accessed through, our website is not incorporated by reference into this report, and you should not consider information on our website to be part of this report. Overview We are a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing our patented piezo-print delivery technology, branded the OptejetTM.
Register and access this filing in:     
  FORM 424B5
    TABLE OF CONTENTS
    PROSPECTUS SUPPLEMENT SUMMARY
    THE OFFERING
    RISK FACTORS
    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DILUTION
    UNDERWRITING
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND ADDITIONAL INFORMATION
      INCORPORATION OF DOCUMENTS BY REFERENCE
    RISK FACTORS
    USE OF PROCEEDS
    PLAN OF DISTRIBUTION
    DESCRIPTION OF OUR CAPITAL STOCK
    DESCRIPTION OF WARRANTS
    DESCRIPTION OF DEBT SECURITIES
    DESCRIPTION OF THE UNITS